Gainers
- Virax Biolabs Group VRAX shares rose 34.2% to $0.81 during Wednesday's pre-market session. The market value of their outstanding shares is at $12.5 million.
- Genprex GNPX stock increased by 15.78% to $1.1. The company's market cap stands at $57.1 million.
- Matinas BioPharma Hldgs MTNB shares moved upwards by 14.85% to $0.58. The market value of their outstanding shares is at $126.0 million.
- VYNE Therapeutics VYNE stock increased by 14.37% to $3.58. The market value of their outstanding shares is at $11.6 million.
- BiondVax Pharmaceuticals BVXV stock rose 14.35% to $2.23. The market value of their outstanding shares is at $4.2 million. The company's, Q4 earnings came out 2 days ago.
- Legend Biotech LEGN shares rose 13.89% to $59.5. The market value of their outstanding shares is at $9.8 billion.
Losers
- Femasys FEMY stock declined by 26.2% to $0.93 during Wednesday's pre-market session. The company's market cap stands at $11.0 million.
- Allarity Therapeutics ALLR stock decreased by 23.28% to $0.89.
- SAB Biotherapeutics SABS stock fell 14.66% to $0.93. The company's market cap stands at $46.8 million. As per the news, the Q4 earnings report came out 3 days ago.
- Indaptus Therapeutics INDP shares decreased by 14.11% to $2.12. The company's market cap stands at $17.8 million.
- CNS Pharma CNSP shares declined by 12.23% to $1.79. The market value of their outstanding shares is at $3.9 million.
- Dermata Therapeutics DRMA stock fell 9.89% to $2.28. The company's market cap stands at $1.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CNSPCNS Pharmaceuticals Inc
$0.09530.21%
DRMADermata Therapeutics Inc
$1.21-1.63%
FEMYFemasys Inc
$1.11-5.93%
GNPXGenprex Inc
$0.5619-9.17%
INDPIndaptus Therapeutics Inc
$0.9100-%
LEGNLegend Biotech Corp
$37.31-2.07%
MTNBMatinas BioPharma Holdings Inc
--%
SABSSAB Biotherapeutics Inc
$2.10-4.11%
VRAXVirax Biolabs Group Ltd
$1.65-2.37%
VYNEVYNE Therapeutics Inc
$2.360.43%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in